Patient who received genetically modified pig heart in groundbreaking transplant surgery dies
CTV
A 57-year-old Maryland man who had received a genetically modified pig heart in a first-of-its-kind transplant surgery has died, the University of Maryland Medical Center said Wednesday.
David Bennett died on Tuesday after his condition began to deteriorate several days ago, the medical center said. He was given palliative care and was able to communicate with his family during his final hours, according to the news release.
"We are devastated by the loss of Mr. Bennett. He proved to be a brave and noble patient who fought all the way to the end. We extend our sincerest condolences to his family," Dr. Bartley P. Griffith, the surgeon who transplanted the pig heart at the University of Maryland Medical Center, said in a statement. "Mr. Bennett became known by millions of people around the world for his courage and steadfast will to live."
Bennett had terminal heart disease, and had received a transplant on January 7. Bennett was deemed ineligible for a conventional heart transplant or an artificial heart pump after reviews of his medical records, and the pig heart was the only available option, the medical center said at the time.
Revivicor, a regenerative medicine company based in Virginia, had provided the heart. Three genes that are responsible for rejection of pig organs by human immune systems were removed from the donor pig, and one gene was taken out to prevent excessive pig heart tissue growth. Six human genes responsible for immune acceptance were inserted.
Tropical storm Sara drenches Honduras’ northern coast, with flash flooding and mudslides in forecast
Tropical storm Sara stalled over Honduras on Saturday. The area could see life-threatening flash flooding and mudslides through the weekend.